These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29115557)

  • 1. Hypoxia induces differential expression patterns of osteopontin and CD44 in colorectal carcinoma.
    Wohlleben G; Hauff K; Gasser M; Waaga-Gasser AM; Grimmig T; Flentje M; Polat B
    Oncol Rep; 2018 Jan; 39(1):442-448. PubMed ID: 29115557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reciprocal interactions between tumor-associated macrophages and CD44-positive cancer cells via osteopontin/CD44 promote tumorigenicity in colorectal cancer.
    Rao G; Wang H; Li B; Huang L; Xue D; Wang X; Jin H; Wang J; Zhu Y; Lu Y; Du L; Chen Q
    Clin Cancer Res; 2013 Feb; 19(4):785-97. PubMed ID: 23251004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The osteopontin-CD44 axis in hepatic cancer stem cells regulates IFN signaling and HCV replication.
    Shirasaki T; Honda M; Yamashita T; Nio K; Shimakami T; Shimizu R; Nakasyo S; Murai K; Shirasaki N; Okada H; Sakai Y; Sato T; Suzuki T; Yoshioka K; Kaneko S
    Sci Rep; 2018 Sep; 8(1):13143. PubMed ID: 30177680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD44v6 engages in colorectal cancer progression.
    Ma L; Dong L; Chang P
    Cell Death Dis; 2019 Jan; 10(1):30. PubMed ID: 30631039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CD44 standard isoform contributes to radioresistance of pancreatic cancer cells.
    Tsubouchi K; Minami K; Hayashi N; Yokoyama Y; Mori S; Yamamoto H; Koizumi M
    J Radiat Res; 2017 Nov; 58(6):816-826. PubMed ID: 29106581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteopontin-4 and Osteopontin-5 splice variants are expressed in several tumor cell lines.
    Silva GR; Mattos DS; Bastos ACF; Viana BPPB; Brum MCM; Ferreira LB; Gimba ERP
    Mol Biol Rep; 2020 Oct; 47(10):8339-8345. PubMed ID: 33006711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteopontin-dependent CD44v6 expression and cell adhesion in HepG2 cells.
    Gao C; Guo H; Downey L; Marroquin C; Wei J; Kuo PC
    Carcinogenesis; 2003 Dec; 24(12):1871-8. PubMed ID: 12949055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of osteopontin and CD44 correlates with infertility status in PCOS patients.
    Paravati R; De Mello N; Onyido EK; Francis LW; Brüsehafer K; Younas K; Spencer-Harty S; Conlan RS; Gonzalez D; Margarit L
    J Mol Med (Berl); 2020 Dec; 98(12):1713-1725. PubMed ID: 33047155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteopontin promotes integrin activation through outside-in and inside-out mechanisms: OPN-CD44V interaction enhances survival in gastrointestinal cancer cells.
    Lee JL; Wang MJ; Sudhir PR; Chen GD; Chi CW; Chen JY
    Cancer Res; 2007 Mar; 67(5):2089-97. PubMed ID: 17332338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD44v6 regulates growth of brain tumor stem cells partially through the AKT-mediated pathway.
    Jijiwa M; Demir H; Gupta S; Leung C; Joshi K; Orozco N; Huang T; Yildiz VO; Shibahara I; de Jesus JA; Yong WH; Mischel PS; Fernandez S; Kornblum HI; Nakano I
    PLoS One; 2011; 6(9):e24217. PubMed ID: 21915300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of the human osteopontin promoter by ERRα in colorectal cancer.
    Boudjadi S; Bernatchez G; Beaulieu JF; Carrier JC
    Am J Pathol; 2013 Jul; 183(1):266-76. PubMed ID: 23680656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of CD44 alternative splice pattern in the course of human colorectal adenocarcinoma progression.
    Bánky B; Rásó-Barnett L; Barbai T; Tímár J; Becságh P; Rásó E
    Mol Cancer; 2012 Nov; 11():83. PubMed ID: 23151220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced cell surface CD44 variant (v6, v9) expression by osteopontin in breast cancer epithelial cells facilitates tumor cell migration: novel post-transcriptional, post-translational regulation.
    Khan SA; Cook AC; Kappil M; Günthert U; Chambers AF; Tuck AB; Denhardt DT
    Clin Exp Metastasis; 2005; 22(8):663-73. PubMed ID: 16691370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteopontin-enhanced hepatic metastasis of colorectal cancer cells.
    Huang J; Pan C; Hu H; Zheng S; Ding L
    PLoS One; 2012; 7(10):e47901. PubMed ID: 23112867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent expression of the high molecular, 673-bp CD44v3,v8-10 variant in colorectal adenomas and carcinomas.
    Kopp R; Fichter M; Schalhorn G; Danescu J; Classen S
    Int J Mol Med; 2009 Nov; 24(5):677-83. PubMed ID: 19787202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of hypoxia and irradiation on osteopontin expression in head and neck cancer and glioblastoma cell lines.
    Wohlleben G; Scherzad A; Güttler A; Vordermark D; Kuger S; Flentje M; Polat B
    Radiat Oncol; 2015 Aug; 10():167. PubMed ID: 26259597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of osteopontin promotes the radiosensitivity of breast cancer cells by reducing the expression of hypoxia inducible factor 1 and vascular endothelial growth factor.
    Yang L; Zhao W; Zuo WS; Wei L; Song XR; Wang XW; Zheng G; Zheng MZ
    Chin Med J (Engl); 2012 Jan; 125(2):293-9. PubMed ID: 22340562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of osteopontin expression on the metastatic growth of CC531 rat colorectal carcinoma cells in rat liver.
    Uhlmann ME; Georges RB; Boleij A; Eyol E; Kubarenko A; Adwan H; Berger MR
    Cancer Gene Ther; 2011 Nov; 18(11):795-805. PubMed ID: 21852811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common Variants in Osteopontin and
    Gałecki S; Gdowicz-Kłosok A; Deja R; Masłyk B; Giglok M; Suwiński R; Butkiewicz D
    Cells; 2023 Nov; 12(23):. PubMed ID: 38067149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression patterns of the hypoxia-related genes osteopontin, CA9, erythropoietin, VEGF and HIF-1alpha in human glioma in vitro and in vivo.
    Said HM; Hagemann C; Staab A; Stojic J; Kühnel S; Vince GH; Flentje M; Roosen K; Vordermark D
    Radiother Oncol; 2007 Jun; 83(3):398-405. PubMed ID: 17524506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.